BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35645542)

  • 1. c-MET immunohistochemical expression in sporadic and inflammatory bowel disease associated lesions.
    Halliday G; Porter RJ; Black CJ; Arends MJ; Din S
    World J Gastroenterol; 2022 Apr; 28(13):1338-1346. PubMed ID: 35645542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-conventional dysplasia in inflammatory bowel disease is more frequently associated with advanced neoplasia and aneuploidy than conventional dysplasia.
    Lee H; Rabinovitch PS; Mattis AN; Lauwers GY; Choi WT
    Histopathology; 2021 May; 78(6):814-830. PubMed ID: 33155325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia.
    Gui X; Liu S; Yan Y; Gao Z
    World J Gastroenterol; 2013 Jul; 19(28):4504-10. PubMed ID: 23901225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted next-generation sequencing supports serrated epithelial change as an early precursor to inflammatory bowel disease-associated colorectal neoplasia.
    Singhi AD; Waters KM; Makhoul EP; Parian A; Lazarev MG; Proksell SS; Dueker JM; Schwartz MB; Wald AI; Nikiforova MN; Montgomery EA
    Hum Pathol; 2021 Jun; 112():9-19. PubMed ID: 33727167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of LINE-1 Hypomethylation With Size and Pathologic Extent of Dysplasia in Colorectal Tubular Adenomas.
    Jiang AC; Buckingham L; Bishehsari F; Sutherland S; Ma K; Melson JE
    Clin Transl Gastroenterol; 2021 Jun; 12(6):e00369. PubMed ID: 34060495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
    Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
    Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of low and high-grade dysplasia in inflammatory bowel disease: the gastroenterologists' perspective and current practice in the United Kingdom.
    Thomas T; Nair P; Dronfield MW; Mayberry JF
    Eur J Gastroenterol Hepatol; 2005 Dec; 17(12):1317-24. PubMed ID: 16292084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of IL6/IL6R-STAT3-SOCS3 signaling pathway in IBD-associated colorectal dysplastic lesions as compared to sporadic colorectal adenomas in non-IBD patients.
    Gui X; Iacucci M; Ghosh S
    Pathol Res Pract; 2020 Nov; 216(11):153211. PubMed ID: 32979687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients.
    Torres C; Antonioli D; Odze RD
    Am J Surg Pathol; 1998 Mar; 22(3):275-84. PubMed ID: 9500769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Colorectal Neoplasia Risk in Patients with Inflammatory Bowel Disease and Serrated Polyps with Dysplasia.
    de Jong ME; Nagtegaal ID; Vos S; van der Post RS; van Herwaarden Y; Derikx LAAP; Hoentjen F
    Dig Dis Sci; 2022 Dec; 67(12):5647-5656. PubMed ID: 35380348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and Dysplasia.
    Cremer A; Demetter P; De Vos M; Rahier JF; Baert F; Moreels T; Macken E; Louis E; Ferdinande L; Fervaille C; Dedeurwaerdere F; Bletard N; Driessen A; De Hertogh G; Vermeire S; Franchimont D;
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1528-1536.e5. PubMed ID: 31202983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy.
    Ten Hove JR; Mooiweer E; van der Meulen de Jong AE; Dekker E; Ponsioen CY; Siersema PD; Oldenburg B
    Endoscopy; 2017 Feb; 49(2):161-168. PubMed ID: 27951611
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypermucinous, Goblet Cell-Deficient and Crypt Cell Dysplasias in Inflammatory Bowel Disease are Often Associated with Flat/Invisible Endoscopic Appearance and Advanced Neoplasia on Follow-Up.
    Choi WT; Salomao M; Zhao L; Alpert L; Setia N; Liao X; Drage MG; Westerhoff M; Cheng J; Lauwers GY; Ko HM
    J Crohns Colitis; 2022 Jan; 16(1):98-108. PubMed ID: 34232295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.
    Eluri S; Parian AM; Limketkai BN; Ha CY; Brant SR; Dudley-Brown S; Efron JE; Fang SG; Gearhart SL; Marohn MR; Meltzer SJ; Bashar S; Truta B; Montgomery EA; Lazarev MG
    Dig Dis Sci; 2017 Dec; 62(12):3586-3593. PubMed ID: 28631086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The level of epidermal growth factor receptors expression is correlated with the advancement of colorectal adenoma: validation of a surface biomarker.
    Williet N; Petcu CA; Rinaldi L; Cottier M; Del Tedesco E; Clavel L; Dumas O; Jarlot C; Bouarioua N; Roblin X; Peoc'h M; Phelip JM
    Oncotarget; 2017 Mar; 8(10):16507-16517. PubMed ID: 28157706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the spectrum of serrated epithelium encountered in inflammatory bowel disease.
    Waters KM; Singhi AD; Montgomery EA
    Hum Pathol; 2023 Feb; 132():126-134. PubMed ID: 35753410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA content analysis of colorectal serrated lesions detects an aneuploid subset of inflammatory bowel disease-associated serrated epithelial change and traditional serrated adenomas.
    Choi WT; Wen KW; Rabinovitch PS; Huang D; Mattis AN; Gill RM
    Histopathology; 2018 Sep; 73(3):464-472. PubMed ID: 29772067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Significance of Sessile Serrated Polyps in Inflammatory Bowel Disease.
    Jackson WE; Achkar JP; Macaron C; Lee L; Liu X; Pai RK; Lopez R; Burke CA; Allende DS
    Inflamm Bowel Dis; 2016 Sep; 22(9):2213-20. PubMed ID: 27508509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation.
    Cao D; Wilentz RE; Abbruzzese JL; Ho L; Maitra A
    Int J Gastrointest Cancer; 2005; 36(1):39-46. PubMed ID: 16227634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p27 expression in inflammatory bowel disease-associated neoplasia. Further evidence of a unique molecular pathogenesis.
    Walsh S; Murphy M; Silverman M; Odze R; Antonioli D; Goldman H; Loda M
    Am J Pathol; 1999 Nov; 155(5):1511-8. PubMed ID: 10550307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.